In a proposed ruling, a Connecticut Freedom of Information Commission hearing officer has determined the Insurance Department failed to prove the records were exempt from disclosure and has recommended a rare civil fine against Commissioner Katharine Wade. The commission is scheduled to consider the case June 28.
Updated at 2 p.m.
WASHINGTON — Anthem’s $54 billion merger deal with Cigna is considered to be on life support after a federal appeals court ruled last week it violated antitrust law. But on Friday, Anthem said it is appealing that decision to the U.S. Supreme Court.
WASHINGTON — Anthem’s effort to merge with Cigna, which seemed to end with a huge thud when a federal court ruled the $54 billion deal is anti-competitive, may have been given new life – but the odds are long and Connecticut could stand in the way.
WASHINGTON — The messy divorce between Anthem and Cigna took another turn Wednesday in a Delaware court that will be the scene of further expensive legal battling over the insurers’ merger attempt.
WASHINGTON — The tumultuous relationship between proposed merger partners Anthem and Cigna continued Tuesday as Cigna called for an end to the deal and demanded about $15 billion from Anthem – which said it is “committed to closing the transaction.”
WASHINGTON — After a federal judge blocked the deal last month, Aetna on Tuesday announced it would no longer pursue a $37 billion merger with Humana. U.S. District Judge John Bates ruled last month that a merger of the health insurers would result in a lack of competition in the Medicare Advantage market.
WASHINGTON — Anthem said Thursday it will appeal a federal court’s decision to block the health insurer’s planned merger with Cigna. The decision to appeal came quickly on the heels of U.S. District Judge Amy Berman Jackson’s ruling late Wednesday that the $54 billion merger would reduce competition in dozens of insurance markets across the nation.
WASHINGTON — The U.S. Justice Department won a second big health insurer antitrust case late Wednesday when a federal judge blocked a proposed merger between Anthem and Cigna. The Justice Department said the merger would stiffle competition, resulting in higher premiums and poorer medical care.
WASHINGTON — Aetna CEO Mark Bertolini said the insurer isn’t likely to expand its participation in state exchanges in 2018. Bertolini said he is working with the Trump administration on a transition to an ACA replacement.
WASHINGTON — The day after a federal judge dealt a crusing blow to Aetna’s plans to merge with Humana, the insurance companies’ CEOs said they were still mulling over whether to appeal the decision.
Updated at 4:35 p.m.
WASHINGTON — A federal judge on Monday rejected a proposed merger between Aetna and Humana, saying the $37 billion deal would “be likely to substantially lessen competition” in the Medicare Advantage market. Aetna is considering an appeal.
WASHINGTON — The antitrust trial over a proposed merger between Aetna and Humana wrapped up Wednesday, with U.S. District Court Judge John Bates asking probing questions of both Justice Department lawyers seeking to block the deal and attorneys for the insurers defending their plan.
WASHINGTON — Hostilities between proposed merger partners Anthem and Cigna were on full display Tuesday at a key point of a U.S. antitrust trial over the deal. Cigna attorney Rick Rule said the company did not sign a key closing document because it did not agree with Anthem’s characterizations of the testimony of certain Cigna witnesses.
Updated at 6:35 p.m.
WASHINGTON — Justice Department attorneys on Monday continued to try to undercut arguments by Aetna CEO Mark Bertolini that his company’s Medicare Advantage program competes with government-run Medicare.
Updated at 4:57 p.m.
WASHINGTON — Opening salvos were fired Monday in the antitrust case against the proposed merger of Aetna and Humana, with Justice Department attorneys arguing the tie-up would mean sharp price hikes for Medicare Advantage plans and a disintegration of choice for people purchasing insurance on Affordable Care Act exchanges.